Understanding 3-Ethoxy-4-Ethoxycarbonyl Phenylacetic Acid: Direct Insights from the Manufacturer

Introduction to Our Core Product

We’ve spent years perfecting our process to produce 3-Ethoxy-4-Ethoxycarbonyl Phenylacetic Acid to meet the expectations set by pharmaceutical and fine chemical partners around the world. This compound, known among our team for its distinctive structure and reliable behavior in syntheses, earns a respected place in our specialty carboxylic acid portfolio. In our experience, customers turn to this product when they require a precise reagent for constructing complex molecules, including certain APIs (Active Pharmaceutical Ingredients) and advanced intermediates.

Product Case: Why 3-Ethoxy-4-Ethoxycarbonyl Phenylacetic Acid?

We recognize the demands chemists face: consistency in performance, reliability in supply, and chemical purity high enough to let subtle reactions proceed with little interference. Our 3-Ethoxy-4-Ethoxycarbonyl Phenylacetic Acid, available under catalog model EECPA-98, offers a minimum verified purity of 98 percent by HPLC, with our most recent campaign batches trending above 99 percent. We manufacture in batches ranging from 5 to 200 kg, giving flexibility in project sizing, so research teams and production sites receive fresh material with close control over batch aging.

The molecular formula is C13H16O5, with a molecular weight of 252.27 g/mol. The compound presents as a pale solid—crystalline and non-hygroscopic under standard packaging conditions. We package the product in high-density polyethylene drums or fluorinated bottles, in line with the compatibility requirements of this acid derivative.

Applications Drawn from Real-World Use

Teams in both process and research labs rely on this compound for selective acylation steps and as an acetic acid-type nucleophile in coupling reactions. Our largest clients source it to build precursors for antihypertensive agents as well as for advanced intermediates used in the preparation of custom enzyme inhibitors. Several clients integrate it at the key step for phenylacetic backbone construction, taking advantage of the dual ethoxy- and ethoxycarbonyl- substituents, which can be differentially removed or further functionalized by standard organic transformations (like hydrolysis or transesterification).

Method developers appreciate the reproducibility we reach batch-to-batch. By controlling the ratio of starting reagents and fine-tuning reaction temperature profiles, we limit side-product formation below 0.3 percent by mass, measured against high-sensitivity LC-MS analytics. The resulting product supports scale-up, with little need to revisit process conditions after qualifying the initial pilot batch. Production chemists in our network point out that this level of control simplifies cleaning validation and documentation when taking the chemistry from bench to larger reactors.

Why Consistency Matters

Small deviations in the profile of phenylacetic acid derivatives can ruin a day’s work, especially if impurity levels creep above detection thresholds in regulated environments. Our team invests in regular line calibration, and we rely on validated methods for both process-scale and QC lab testing. With every lot, we guarantee tight conformance to our monograph requirements, including meets-all colorimetric endpoints for trace iron and halide content.

Each time a process engineer calls us about “product drift” or shifting impurity profiles, we look first at the in-process records and, frequently, the storage history. We recognized some years ago that shipping delays and improper drum handling contributed as much to unexpected assay declines as anything in the chemistry. Now, our shipping team uses only route-tested logistics partners and documents each chain-of-custody event for every container. This has cut return incidents in half over three years, giving customers more control over their scheduling and GMP documentation.

Differentiation from Other Phenylacetic Acids

Not all phenylacetic acids perform the same in real-world synthesis. Several years ago, a partner presented us with a problem where they substituted a simple 4-ethoxycarbonyl phenylacetic acid hoping to save time, but the alternate compound failed to deliver acceptable selectivity in their key cyclization. Our product’s extra ethoxy group at the 3-position changes the compound’s reactivity profile, improving its electron-donating properties and affecting both solubility and reactivity with acylating agents. Customers report that the dual substitution pattern provides better control over regioselective transformations, especially useful in constructing asymmetric intermediates.

Subtle distinctions in solubility—both in polar and nonpolar solvents—open up flexible workups in both aqueous and organic phases. Compared to simpler analogs, our product solves separation challenges by giving sharper phase splits after extractions, reducing emulsion formation and loss of material in the mother liquor. Even small savings on each batch accumulate, lowering per-kg conversion costs and reducing waste chemical disposal needs.

Partnerships in Development and Customization

Some years back, a client needed a narrow particle size for use in a continuous-flow system. We adjusted our final precipitation and filtration protocols, working through several trials on our pilot line to achieve a D90 of less than 75 microns. This tailored approach increased their reaction throughput by 12 percent when switching from beaker-scale tests to an inline reactor. The open communication between our process and theirs uncovered some subtle heat transfer improvements once the particle morphology matched their needs. We keep these lessons in our technical file so the next inquiry benefits from each success.

With changing regulatory requirements, requests for more data on residual solvents or bioburden sometimes reach us weeks before an audit deadline. We maintain deep batch archives and provide full CoA and trace impurity reports—including all chromatographic and spectroscopic supporting evidence—on request. This saves regulatory departments time retrieving compliance packages and reduces missed submission deadlines.

Sustainability and Production Integrity

Our experience tells us that small improvements in production get magnified continually along the value chain. We focus on minimizing solvent use at each isolation step. Real-time process analytics give us early warnings if the stoichiometric profile shifts outside our operating range—saving rework or downstream yield loss. Our solvent recovery setup feeds back over 75 percent of reclaimed material into future batches, shrinking our environmental impact and helping our customers report better sustainability data in their value-added product summaries.

Our waste handling partners participate in spot audits, and we welcome periodic client site visits. In 2023, a longtime client completed a one-day audit of our line, and even suggested improvements in our final packaging procedure—something we adopted to reduce minor handling damages in transit. All participants shared their findings, so our process now benefits not just our team, but others in the supply chain.

Quality Stakes in Pharmaceutical Workflows

When a new synthesis route gets discussed, especially for APIs or regulated intermediates, chemists rely on every input to meet or surpass monograph or buyer requirements. We routinely engage with formulation specialists who require validated stability and shelf-life data, and our product holds its assay for at least 24 months under standard storage. Routine stress testing with forced degradation has shaped our packaging practice—especially our switch to amber containers for clients running long-term trials.

Quality variances affect execution down the line. We learned from early feedback that even a small change in particle habit could cause issues in downstream filtration or in blending. Applying that lesson, we now send each new batch for a micro-sized sample to customer labs for a small-scale compatibility run before scheduling the full-scale dispatch.

Supporting New Research and Scale-Up

New chemical entities or reformulated actives sometimes demand large amounts of trial material. We commit to making material available out of scheduled campaigns so our partners can stick to their own research timelines. On more than one occasion, a pilot group has come to us after a failed scale-up using third-party bulk inventory. By providing material validated from our current commercial batch, we've seen scale-up success rates recover, keeping programs moving and lowering attrition rates in chemical development.

Our technical staff remains involved, answering questions from lab chemists and plant engineers alike. This comes from experience with failed campaigns—factors as simple as drum headspace miscalculations or differences in supplier storage temperatures change practical yield by several percentage points. Open lines of communication, combined with reliable technical documentation, restore confidence and reduce costly troubleshooting on the production floor.

Comparisons Beyond Just Purity

Many chemists focus first on chemical purity listed on a CoA, but over years of fielding technical calls, we’ve seen that physical consistency influences product outcome just as much. Our product’s homogenous appearance, stable melting point, and consistently easy flow through feeder systems guarantee repeatable dispensing on both small and large scales.

Some commercial phenylacetic acid derivatives, available through less controlled channels, have shipped with minor color impurities or low-level particulate contamination. These off-spec features stress HPLC columns and interfere with automated handling, costing time and sometimes triggering process shutdowns. By tracing raw material lots and validating our purification schemes, we protect our buyers from unplanned halts.

End-Use Trends and Customer Feedback

End-use reports continue to shape our priorities. Process chemists in pharmaceutical research send us data on reaction behavior in real time—feedback on filtration rates, solubility in proprietary solvent blends, and product shelf life under process storage conditions. This two-way learning cycle lets us phase in improvements iteratively, always aiming for higher yields and fewer complaints.

Over the past five years, customers asked us to help streamline their final workups. We introduced a low-residue packaging option made for direct introduction into reactors, cutting cross-contamination concerns. Several customers now report smoother clean-in-place cycles, directly attributing improvements to packaging upgrades rather than process changes.

Reliability for Both Routine and Pioneering Projects

Not all projects run on large batch schedules. We routinely supply single-kg quantities or even smaller R&D samples for molecule scouting and method development. Our operations team learned long ago that short lead times matter most at these early stages, and we expedite internal QC and packing for these orders.

Pouring over client histories, it becomes clear that seamless research transitions into commercial production when researchers work with the same batch-proven material used for early trials. Keeping tight cycle times reduces handoff errors and redundancy. Whether supplying a multinational or a small CRO, our product history demonstrates that direct-from-source supply shortens time to delivery and saves administrative effort in supplier evaluation.

Commitment to Transparency and Learning

Openly sharing both our successes and the challenges faced in our production cycles has built trust with our partners and customers. Some difficulties, such as unplanned column loading or prolonged drying times, only became clear after intensive process monitoring and shared root-cause analysis with customer teams. These experiences lead directly to stronger quality oversight and better data in our specification sheets.

Whenever a specification element presents ambiguity—such as ambiguous micro-impurity readings or borderline residual solvent levels—we quickly convene technical meetings with analysis experts, update our control documentation, and relay all findings to active clients. This transparency fosters cooperation and gives partners confidence that their feedback informs future operations.

Looking Ahead: Setting the Standard for Advanced Intermediates

Our team sees every kilogram produced not as a commodity, but as a building block for both everyday and breakthrough applications. Over years spent in both chemical engineering and quality assurance, we’ve watched how reliable intermediates empower drug discovery, scale-up, and process optimization. The knowledge gathered from countless production cycles, audits, customer troubleshooting sessions, and in-plant improvements drives our commitment to delivering this specialty acid to exacting standards.

Final outcomes speak louder than technical manuals. Process efficiency, product integrity, and smooth project flow all tie back to the starting materials. Our role as direct manufacturer means we understand each detail, adapt processes in response to direct operating feedback, and invest continually in both production expertise and customer partnership.